OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

OpenAI researcher Miles Wang is leaving to start an AI drug discovery company. He's in talks to raise around $200M at a $2B valuation, with Lightspeed discussing a lead role. Several other OpenAI researchers are expected to join. Wang disputed the funding figures and company description, though the post doesn't specify which parts. Talks are ongoing and details could change.

Why it matters: OpenAI researcher departure, AI drug discovery, $2B valuation — three signals the industry tracks. TechCrunch exclusive with concrete details (raise size, lead investor), but the subject has disputed parts of the report and talks are ongoing, capping the score below 85.